Long-term outcomes of pericardial strip versus prosthetic ring annuloplasty for secondary tricuspid regurgitation by a minimally invasive approach.


Journal

Journal of cardiothoracic surgery
ISSN: 1749-8090
Titre abrégé: J Cardiothorac Surg
Pays: England
ID NLM: 101265113

Informations de publication

Date de publication:
21 Nov 2021
Historique:
received: 23 07 2021
accepted: 08 11 2021
entrez: 22 11 2021
pubmed: 23 11 2021
medline: 24 11 2021
Statut: epublish

Résumé

This study was conducted to compare the outcomes of prosthetic ring versus autologous pericardial strip for the treatment of functional tricuspid regurgitation during left-sided valve surgery by minimally invasive approach. From January 2008 and July 2016, autologous pericardial strip (group P-TAP) was used in 109 patients, and prosthetic ring (group R-TAP) in 115 patients. The primary outcomes were long-term overall survival, development of patch degeneration, and significant tricuspid regurgitation recurrence. The second outcome was the assessment of right ventricular functional parameters. Operative mortality was 1 case (0.9%) in the R-TAP group. At the time of hospital discharge only one patient (0.9%) in the R-TAP group had grade III+ tricuspid regurgitation, and none had grade IV+. Mean follow-up was 94.1 ± 24.5 months. Mild and moderate tricuspid regurgitation recurrence was 3.7% and 4.5% (P-TAP vs. R-TAP groups, p = 0.99). Severe regurgitation was observed in 1.8% of cases only in the R-TAP group (p = 0.49). There were no reoperations. Late mortality was 3.7% and 5.4% (P-TAP vs. R-TAP groups, p = 0.75). Freedom from death, all causes, were comparable among groups (log-rank p = 0.45). There were no statistically significant differences between two groups in TAPSE, left ventricular end-diastolic diameter, left ventricular ejection fraction, and left atrial diameter. Tricuspid annuloplasty using an autologous pericardial strip in patients undergoing minimally invasive surgery is associated to similar long results (survival, late tricuspid regurgitation, and functional echocardiographic parameters) than annuloplasty with a prosthetic ring. In particular, the pericardial strip over time does not develop any degeneration or retraction.

Sections du résumé

BACKGROUND BACKGROUND
This study was conducted to compare the outcomes of prosthetic ring versus autologous pericardial strip for the treatment of functional tricuspid regurgitation during left-sided valve surgery by minimally invasive approach.
METHODS METHODS
From January 2008 and July 2016, autologous pericardial strip (group P-TAP) was used in 109 patients, and prosthetic ring (group R-TAP) in 115 patients. The primary outcomes were long-term overall survival, development of patch degeneration, and significant tricuspid regurgitation recurrence. The second outcome was the assessment of right ventricular functional parameters.
RESULTS RESULTS
Operative mortality was 1 case (0.9%) in the R-TAP group. At the time of hospital discharge only one patient (0.9%) in the R-TAP group had grade III+ tricuspid regurgitation, and none had grade IV+. Mean follow-up was 94.1 ± 24.5 months. Mild and moderate tricuspid regurgitation recurrence was 3.7% and 4.5% (P-TAP vs. R-TAP groups, p = 0.99). Severe regurgitation was observed in 1.8% of cases only in the R-TAP group (p = 0.49). There were no reoperations. Late mortality was 3.7% and 5.4% (P-TAP vs. R-TAP groups, p = 0.75). Freedom from death, all causes, were comparable among groups (log-rank p = 0.45). There were no statistically significant differences between two groups in TAPSE, left ventricular end-diastolic diameter, left ventricular ejection fraction, and left atrial diameter.
CONCLUSIONS CONCLUSIONS
Tricuspid annuloplasty using an autologous pericardial strip in patients undergoing minimally invasive surgery is associated to similar long results (survival, late tricuspid regurgitation, and functional echocardiographic parameters) than annuloplasty with a prosthetic ring. In particular, the pericardial strip over time does not develop any degeneration or retraction.

Identifiants

pubmed: 34802429
doi: 10.1186/s13019-021-01723-4
pii: 10.1186/s13019-021-01723-4
pmc: PMC8607670
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338

Informations de copyright

© 2021. The Author(s).

Références

Interact Cardiovasc Thorac Surg. 2009 Dec;9(6):1009-20
pubmed: 19778956
Heart Surg Forum. 2008;11(1):E4-8
pubmed: 18270139
Circulation. 2006 Jul 4;114(1 Suppl):I582-7
pubmed: 16820642
Am Heart J. 2008 Apr;155(4):732-7
pubmed: 18371484
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
J Am Coll Cardiol. 2002 May 1;39(9):1450-5
pubmed: 11985906
Eur J Cardiothorac Surg. 2008 Apr;33(4):600-6
pubmed: 18272386
Ann Thorac Surg. 2008 Nov;86(5):1485-92; discussion 1493
pubmed: 19049736
J Thorac Cardiovasc Surg. 2008 Apr;135(4):732-8
pubmed: 18374749
Circulation. 2006 Jul 4;114(1 Suppl):I577-81
pubmed: 16820641
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Eur Heart J. 2012 Oct;33(19):2451-96
pubmed: 22922415
Eur J Cardiothorac Surg. 2000 Apr;17(4):431-9
pubmed: 10773567
J Am Coll Cardiol. 2012 Feb 21;59(8):703-10
pubmed: 22340261
Circulation. 2010 May 4;121(17):1934-40
pubmed: 20404254
Ann Thorac Surg. 2009 Oct;88(4):1209-15
pubmed: 19766809
J Card Surg. 2009 Sep-Oct;24(5):518-21
pubmed: 19740287
J Heart Valve Dis. 2008 Jan;17(1):10-5
pubmed: 18365563

Auteurs

Giuseppe Nasso (G)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy. gnasso@gvmnet.it.

Nicola Di Bari (N)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Giuseppe Santarpino (G)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.
Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy.
Department of Cardiac Surgery, Paracelsus Medical University, Nuremberg, Germany.

Marco Moscarelli (M)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Mario Siro Brigiani (M)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Ignazio Condello (I)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Francesco Bartolomucci (F)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Giuseppe Speziale (G)

GVM Care & Research, Department of Cardiovascular Surgery, Anthea Hospital, Via Camillo Rosalba, 35/38, Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH